Reach out to us on

0120-4918900 Or

Get a call back Click here

Markets

CORPORATE NEWS

You can view News of the company.

Lupin Ltd.

GO

Dec 09, 09:19 BSE 2062.55 ( -8.80 -0.42%)

Volume654

Prev. Close
2071.35

Open Price
2070.70

Today's Low / High

2062.40 2072.00

Bid. Price (Qty.)2062.40 (9)

Offer Price (Qty.)
2063.75 (20)

52 Wk Low / High

1774.00 2403.45

Dec 08 NSE 2070.70( -28.10 -1.34%)

Volume1254639

Prev. Close
2098.80

Open Price
2091.80

Today's Low / High

2055.10 2099.40

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.) 0.00 (0)

52 Wk Low / High

1795.20 2402.90

ISIN No	INE326A01037	Market Cap. ( in Cr. )	94209.48	P/BV	5.48	Book Value ( )	376.64
BSE Code	500257	52 Week High/Low ( )	2403/1774	FV/ML	2/1	P/E(X)	28.71
NSE Code	LUPINEQ	Book Closure	25/07/2025	EPS ( )	71.85	Div Yield (%)	0.58

Date and Time	Headlines
05-Dec-2025 9:32AM	Lupin Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release
05-Dec-2025 9:25AM	Lupin Ltd. - Press Release
04-Dec-2025 2:05PM	Lupin signs exclusive licensing deal with Valorum for biosimilar Armlupeg in the U.S.
04-Dec-2025 1:22PM	Lupin Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release
04-Dec-2025 1:17PM	Lupin Ltd. - Press Release
01-Dec-2025 11:34AM	Lupin gets USFDA approval for Pegfilgrastim Biosimilar
01-Dec-2025 7:45AM	Lupin Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release (...
01-Dec-2025 7:35AM	Lupin Ltd. - Press Release
28-Nov-2025 11:42AM	Lupin Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release
28-Nov-2025 11:39AM	Lupin Ltd. - Press Release